These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 30249425)
21. Healthcare costs associated with varicella and herpes zoster in Norway. Haugnes H; Flem E; Wisløff T Vaccine; 2019 Jun; 37(29):3779-3784. PubMed ID: 31151798 [TBL] [Abstract][Full Text] [Related]
22. Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014. Imafuku S; Dormal G; Goto Y; Jégou C; Rosillon D; Matsuki T J Dermatol; 2020 Mar; 47(3):236-244. PubMed ID: 31953880 [TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States. Curran D; Patterson B; Varghese L; Van Oorschot D; Buck P; Carrico J; Hicks K; Lee B; Yawn B Vaccine; 2018 Aug; 36(33):5037-5045. PubMed ID: 30017145 [TBL] [Abstract][Full Text] [Related]
24. [Activity and cost related to hospital management of herpes zoster in France: focus on ophthalmic herpes zoster]. Berrut G; Vainchtock A; Fernandez J; Bresse X; Baptiste C; De Decker L Geriatr Psychol Neuropsychiatr Vieil; 2014 Dec; 12(4):395-401. PubMed ID: 25515904 [TBL] [Abstract][Full Text] [Related]
25. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above. Curran D; Schmidt-Ott R; Schutter U; Simon J; Anastassopoulou A; Matthews S BMC Infect Dis; 2018 Oct; 18(1):496. PubMed ID: 30285731 [TBL] [Abstract][Full Text] [Related]
26. Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France. Blein C; Gavazzi G; Paccalin M; Baptiste C; Berrut G; Vainchtock A BMC Infect Dis; 2015 Aug; 15():350. PubMed ID: 26286598 [TBL] [Abstract][Full Text] [Related]
27. Significant Associations of Neurological Complications of Herpes Zoster With Stroke in Rheumatoid Arthritis Patients. Liao TL; Lin CH; Chen HH; Chen YM; Lin CC; Chen DY J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724649 [TBL] [Abstract][Full Text] [Related]
28. Economic burden of herpes zoster among skilled nursing facility residents in the United States. Ma L; White RR; Narayanan S; Schmader KE J Am Med Dir Assoc; 2012 Jan; 13(1):54-9. PubMed ID: 21450176 [TBL] [Abstract][Full Text] [Related]
29. Risk and impact of herpes zoster among COPD patients: a population-based study, 2009-2014. Muñoz-Quiles C; López-Lacort M; Díez-Domingo J BMC Infect Dis; 2018 May; 18(1):203. PubMed ID: 29724175 [TBL] [Abstract][Full Text] [Related]
30. Incidence of herpes zoster amongst adults varies by severity of immunosuppression. Schröder C; Enders D; Schink T; Riedel O J Infect; 2017 Sep; 75(3):207-215. PubMed ID: 28676411 [TBL] [Abstract][Full Text] [Related]
31. Burden of Herpes Zoster in the Japanese Population with Immunocompromised/Chronic Disease Conditions: Results from a Cohort Study Claims Database from 2005-2014. Imafuku S; Matsuki T; Mizukami A; Goto Y; de Souza S; Jégou C; Bianco V; Rosillon D; Ito C; Curran D; Holl K Dermatol Ther (Heidelb); 2019 Mar; 9(1):117-133. PubMed ID: 30456446 [TBL] [Abstract][Full Text] [Related]
32. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience. Willis ED; Woodward M; Brown E; Popmihajlov Z; Saddier P; Annunziato PW; Halsey NA; Gershon AA Vaccine; 2017 Dec; 35(52):7231-7239. PubMed ID: 29174682 [TBL] [Abstract][Full Text] [Related]
33. Disease Burden Due to Herpes Zoster among Population Aged ≥50 Years Old in China: A Community Based Retrospective Survey. Li Y; An Z; Yin D; Liu Y; Huang Z; Xu J; Ma Y; Tu Q; Li Q; Wang H PLoS One; 2016; 11(4):e0152660. PubMed ID: 27055179 [TBL] [Abstract][Full Text] [Related]
34. Clinical and immunologic features of recurrent herpes zoster (HZ). Nakamura Y; Miyagawa F; Okazaki A; Okuno Y; Mori Y; Iso H; Yamanishi K; Asada H; J Am Acad Dermatol; 2016 Nov; 75(5):950-956.e1. PubMed ID: 27473453 [TBL] [Abstract][Full Text] [Related]
35. Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster. Dworkin RH; White R; O'Connor AB; Baser O; Hawkins K J Am Geriatr Soc; 2007 Aug; 55(8):1168-75. PubMed ID: 17661954 [TBL] [Abstract][Full Text] [Related]
36. Incidence and risk factors for herpes zoster in patients undergoing liver transplantation. Hamaguchi Y; Mori A; Uemura T; Ogawa K; Fujimoto Y; Okajima H; Kaido T; Uemoto S Transpl Infect Dis; 2015 Oct; 17(5):671-8. PubMed ID: 26201686 [TBL] [Abstract][Full Text] [Related]
37. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology. Goldman GS Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242 [TBL] [Abstract][Full Text] [Related]
39. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Patel MS; Gebremariam A; Davis MM Infect Control Hosp Epidemiol; 2008 Dec; 29(12):1157-63. PubMed ID: 18999945 [TBL] [Abstract][Full Text] [Related]
40. Complications of herpes zoster in cancer patients. Tran TN; Ray GT; Horberg MA; Yawn BP; Castillo AL; Saddier P; Habel LA Scand J Infect Dis; 2014 Jul; 46(7):528-32. PubMed ID: 24796470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]